Breast Cancer Screening in Women with Breast Implants
Women with breast implants should follow the same age-based breast cancer screening guidelines as women without implants, but require specialized mammographic technique using implant displacement (Eklund) views in addition to standard views. 1
Screening Protocol
Age-Based Mammography Guidelines
The screening schedule for women with implants follows standard recommendations based on average risk:
- Ages 40-44: Optional to begin annual screening 1
- Ages 45-54: Annual mammography 2
- Ages 55+: Biennial screening or continue annually based on patient preference 2
- Continue screening as long as life expectancy exceeds 10 years 1
Required Mammographic Technique
Both standard views AND implant displacement (Eklund) views must be obtained during each screening mammogram 3, 4. This dual approach is critical because:
- Standard views show proper breast positioning but have reduced image resolution due to implant obscuration
- Implant displacement views push the implant back against the chest wall, pulling native breast tissue forward for better visualization
- Displacement views show significantly higher cancer visibility, especially in dense breasts with subpectoral implants 5
- Submuscular implant placement allows greater mammographic visualization than subglandular placement 3
Important Technical Considerations
Radiologist expertise matters: Mammograms should be interpreted by radiologists experienced in evaluating augmented patients 3. The implant type (silicone vs. saline) does not affect mammographic density or screening approach—both appear equally radiodense 3.
Supplemental Screening Modalities
When to Add Ultrasound or MRI
Standard guidelines do not recommend routine supplemental screening (ultrasound or MRI) for breast cancer detection in average-risk women with implants 1. However, supplemental imaging becomes appropriate when:
- Dense breast tissue is present on mammography 1
- Clinical concern exists (palpable mass, skin changes, nipple discharge)
- Patient has additional high-risk features (genetic mutation, prior chest radiation, strong family history) 6
For high-risk women with implants, annual breast MRI with contrast is recommended in addition to mammography 6.
Implant Surveillance vs. Cancer Screening
Critical distinction: Implant rupture surveillance is separate from breast cancer screening. The FDA recommends MRI or ultrasound for silicone implant rupture screening starting 5-6 years post-surgery, then every 2-3 years 7, 8. This is for implant integrity assessment, not cancer detection. Saline implant rupture is clinically evident and requires no routine imaging 7.
Clinical Breast Examination
Clinical breast examination is NOT recommended for routine breast cancer screening in average-risk women, including those with implants 2. However, women should practice breast self-awareness and report any changes to their provider 1.
Common Pitfalls to Avoid
- Do not skip displacement views: Standard mammographic views alone are insufficient and may delay cancer detection 5
- Do not confuse implant surveillance with cancer screening: These are separate protocols with different purposes and timing
- Do not assume implants increase cancer risk: Multiple studies confirm implants do not increase breast cancer incidence or worsen prognosis 3, 9
- Do not delay screening: The presence of implants is not a reason to defer or avoid mammography 10
Special Circumstances
For women with unilateral breast swelling, ultrasound evaluation is indicated to assess for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare complication requiring different management 10, 7.